Vicor: Don't Get Off This Ride

Vicor reported record Q3 revenue of $197.1M, up 78.5% year over year; product revenue rose 47%, royalties increased 207%, and gross margin reached 68.3%. The article says supply constraints—not demand—are limiting growth, with Fab 1 nearly full and two new sites targeting roughly 5x capacity from Q2 2027. The author reiterates a Strong Buy despite a 38% share-price drawdown attributed to sector-wide AI hardware selling.

Analysis

The key issue is not whether AI power demand exists, but how much Vicor can ship before its planned capacity arrives. A constrained supplier can have strong pricing and mix, yet still lose incremental sockets when accelerator programs need volume on customers’ schedules. If qualification permits second-sourcing, Monolithic Power Systems and Infineon could capture overflow; however, redesign and validation cycles may limit near-term substitution. The reported royalty acceleration also deserves a quality-of-earnings check: establish its contract basis, recurrence, and cash conversion before extrapolating it into a durable margin run-rate.

Near term (days to weeks), sector flows may dominate company fundamentals; the drawdown alone does not establish cheapness without current valuation and positioning data. Over 1–3 months, watch order/backlog conversion, product shipments versus demand commentary, royalty cash receipts, and any guidance on fab timing or spending. Over 6–18 months, execution at the new sites is the core upside catalyst—but construction, qualification, yield ramp, or customer-program delays could defer monetization and leave the constraint intact. A reversal signal would be shipment growth failing to follow demand, weakening gross margin, or capacity dates slipping. The bullish thesis is plausible, but the article’s conviction is not a substitute for independent evidence that demand converts to deliverable, recurring product revenue.

Key Decisions for Investors

• Do not chase the bullish call solely on the drawdown or one quarter. Verify valuation versus growth, backlog/order conversion, royalty composition and cash collection, and management’s capex and fab milestones before sizing a position.
• If those checks confirm durable product demand and no deterioration in delivery commitments, build a staged, modest VICR long rather than buying the full position ahead of capacity execution; reassess after the next report and any material fab update.
• For a relative-value expression, consider long VICR against a diversified AI-hardware basket only if VICR stabilizes versus the basket and shipment metrics support company-specific recovery. Keep exposure small: sector-wide selling can overwhelm the idiosyncratic thesis.
• Falsify or reduce the thesis if product shipments lag demand commentary, gross margin materially weakens, royalties prove non-recurring or fail to convert to cash, or the 2027 capacity timeline slips.